American Century Companies
ADPT icon

American Century Companies’s Adaptive Biotechnologies ADPT Stock Holding History

American Century Companies’s Portfolio ADPT Stock Details ADPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-71,165
Closed -$364K – 2885
2024
Q3 		$364K Buy
71,165
+25,603
+56% +$112K ﹤0.01% 2577
2024
Q2 		$165K Buy
45,562
+7,039
+18% +$22.3K ﹤0.01% 2762
2024
Q1 		$124K Sell
38,523
-782,914
-95% -$3.03M ﹤0.01% 2840
2023
Q4 		$4.03M Sell
821,437
-2,881
-0.3% -$13.1K ﹤0.01% 1468
2023
Q3 		$4.49M Buy
824,318
+86,478
+12% +$572K ﹤0.01% 1371
2023
Q2 		$4.95M Buy
737,840
+70
+0% +$520 ﹤0.01% 1317
2023
Q1 		$6.51M Buy
737,770
+159,372
+28% +$1.41M 0.01% 1168
2022
Q4 		$4.42M Buy
578,398
+176,441
+44% +$1.37M ﹤0.01% 1267
2022
Q3 		$2.86M Buy
401,957
+220,266
+121% +$2.07M ﹤0.01% 1311
2022
Q2 		$1.47M Buy
181,691
+2,065
+1% +$18.2K ﹤0.01% 1533
2022
Q1 		$2.49M Sell
179,626
-1,878
-1% -$29.5K ﹤0.01% 1335
2021
Q4 		$5.09M Buy
181,504
+57,642
+47% +$1.77M ﹤0.01% 1051
2021
Q3 		$4.21M Buy
123,862
+142
+0.1% +$5.14K ﹤0.01% 1074
2021
Q2 		$5.05M Buy
+123,720
New +$4.81M ﹤0.01% 988
2021
Q1 		– Sell
-948,837
Closed -$56.1M – 2195
2020
Q4 		$56.1M Sell
948,837
-48
-0% -$2.48K 0.04% 372
2020
Q3 		$46.1M Buy
948,885
+147,714
+18% +$6.21M 0.04% 366
2020
Q2 		$38.8M Buy
+801,171
New +$29.2M 0.04% 387
2019
Q3 		– Sell
-177,091
Closed -$8.55M – 1206
2019
Q2 		$8.55M Buy
+177,091
New +$7.85M 0.01% 665

Other funds holding ADPT

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

American Century Companies's ADPT Position: Q4 2024 in Review

American Century Companies sold out of Adaptive Biotechnologies (ADPT) in Q4 2024, closing a stake of 71,165 shares — an estimated $364K sold.

American Century Companies first reported a position in ADPT in Q2 2019 and held it in 18 quarters. The position peaked at $56.1M in Q4 2020. 207 funds tracked by Wall St. Rank hold ADPT as of Q4 2024.

  • American Century Companies reported no remaining Adaptive Biotechnologies position as of Q4 2024 after selling out during the quarter.
  • American Century Companies sold 71,165 Adaptive Biotechnologies shares in Q4 2024, an estimated $364K.
  • American Century Companies first reported a position in Adaptive Biotechnologies in Q2 2019 and held it in 18 quarters.
  • American Century Companies's Adaptive Biotechnologies position peaked at $56.1M in Q4 2020.
  • 207 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q4 2024.

Based on American Century Companies's 13F filing for Q4 2024, filed 11 Feb 2025.